Biophytis announces the drawing of a new tranche of Bonds Redeemable in Cash and New and Existing Shares under its existing convertible bond agreement with Atlas, a specialized.
ABIONYX Pharma Accelerates Its Development by Launching a New Biomanufacturing Campaign Based on the Recently Announced Robust Innovative Process Supported by an Equity-linked Financing Facility streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biophytis / Key word(s): Annual ResultsBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives 07-Apr-2022 / 08:00 CET/CESTBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives Success of Nasdaq IPO in February 2021 €23.9M o.
GROUPE SEB: SEB S.A.: Adjustment of the Exchange Ratio and the Threshold Amounts of the Distributed Dividend per Share of the Bonds Redeemable in Cash and/or in Existing Shares (ORNAE)
Regulatory News:
Following the free allocation of shares on March 3, 2021, decided by the Board of Directors of SEB S.A. (Paris:SK) held on February 23, 2021, making use of the authorization it has been given by the Combined Annual Shareholders General Meeting of May 19, 2020 under the 19
th resolution, the Exchange Ratio and the Threshold Amounts of the Distributed Dividend per Share of the Bonds Redeemable in Cash and/or in Existing Shares (ORNAE) due November 2021 (ISIN code FR0013218807) are adjusted.